Metraipolis › archive › dc_ef68f0f9ebe2

Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer — Europe PMC PMID:40833935

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40833935
DOI
10.1093/jncics/pkaf085
License (as archived)
solo-consultazione
Archived
2026-11-10T04:36:35.878Z
SHA-256 of the archived text
afab1da8a59dd97787fe5c3cc8b75c8e1cb2677e48ea4da338a284dd5b20353c
Stable URL of this page
https://metraipolis.com/documento/dc_ef68f0f9ebe2

How to cite

Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer — Europe PMC PMID:40833935 — Europe PMC (en), https://europepmc.org/article/MED/40833935 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef68f0f9ebe2 (Metraipolis archive dc_ef68f0f9ebe2, sha256 afab1da8a59dd97787fe5c3cc8b75c8e1cb2677e48ea4da338a284dd5b20353c)
BibTeX
@misc{dcef68f0f9ebe2,
  title = {Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer — Europe PMC PMID:40833935},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40833935},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef68f0f9ebe2; sha256 afab1da8a59dd97787fe5c3cc8b75c8e1cb2677e48ea4da338a284dd5b20353c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40833935. Agents can read the archived copy with the MCP tool read_document.